1. The Company and its principal activity
BB Biotech AG (the Company) is listed on the SIX Swiss Exchange, in the «Prime Standard Segment» of the German Exchange as well as in the «Star Segment» of the Italian Exchange and has its registered office in Schaffhausen/Switzerland, Schwertstrasse 6. Its principal activity is to invest in companies active in the biotechnology industry for the purpose of capital appreciation. The investments are held through its wholly owned subsidiaries.
Company |
|
Capital in CHF 1 000 |
|
Capital and voting interest in % |
Biotech Focus N.V., Curaçao |
|
11 |
|
100 |
Biotech Growth N.V., Curaçao |
|
11 |
|
100 |
Biotech Invest N.V., Curaçao |
|
11 |
|
100 |
Biotech Target N.V., Curaçao |
|
11 |
|
100 |